Clinical Trial Update: Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 pediatric trial evaluating cobicistat-boosted atazanavir, cobicistat-boosted darunavir, and emtricitabine/tenofovir alafenamide for HIV/AIDS; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)
• EVOTAZ (atazanavir and cobicistat)
• PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

Sponsor: Gilead Sciences | Conditions: Acquired Immune Deficiency Syndrome (AIDS), HIV Infections | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING